Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03616470
Title Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors GlycoMimetics Incorporated

acute myeloid leukemia


Cytarabine + Etoposide + Mitoxantrone + Uproleselan

Cytarabine + Fludarabine + Idarubicin + Uproleselan

Cytarabine + Etoposide + Mitoxantrone

Cytarabine + Fludarabine + Idarubicin

Age Groups: senior | adult
Covered Countries USA | CAN

No variant requirements are available.